185 related articles for article (PubMed ID: 28803122)
21. Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan.
Huh KY; Lee SW; Lee SB; Kim KT; Jang IJ; Lee S
Clin Pharmacol Drug Dev; 2021 Nov; 10(11):1290-1296. PubMed ID: 33647189
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the Pharmacokinetics of a Fixed-Dose Combination of Rosuvastatin/Metformin Sustained-Release (10/1000 mg) and Separate Tablets in Healthy Male Subjects.
Huh KY; Kim E; Lee H; Jeon I; Suh H; Lee J; Lee Y; Yu KS; Lee S
Clin Pharmacol Drug Dev; 2021 Feb; 10(2):207-213. PubMed ID: 32579298
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects.
Oh M; Shin JG; Ahn S; Kim BH; Kim JY; Shin HJ; Shin HJ; Ghim JL
Drug Des Devel Ther; 2019; 13():991-997. PubMed ID: 31114155
[No Abstract] [Full Text] [Related]
24. Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects.
Hwang I; Park SI; Lee S; Lee B; Yu KS; Jeon JY; Kim MG
Transl Clin Pharmacol; 2018 Mar; 26(1):16-24. PubMed ID: 32055543
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic Interaction Between Telmisartan and Rosuvastatin/Ezetimibe After Multiple Oral Administration in Healthy Subjects.
Kim CH; Kang SI; Shin D
Adv Ther; 2021 Feb; 38(2):1094-1105. PubMed ID: 33326064
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic Interactions and Tolerability of Rosuvastatin and Ezetimibe: A Randomized, Phase 1, Crossover Study in Healthy Chinese Participants.
Wang L; Luan Y; Jia C; Xie X; Zhang Z; Xie X; Wang Q; Hu C; Xie F; Abdel-Moneim M; Hovsepian L; Zhao Z; Yang N; Hou J
Eur J Drug Metab Pharmacokinet; 2023 Jan; 48(1):51-62. PubMed ID: 36437383
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of a new fixed-dose combination of candesartan cilexetil, hydrochlorothiazide, and rosuvastatin in healthy adult subjects.
Yerino GA; Feleder EC; Halabe EK; Diaz L; Sakson M; Iglesias M; Haddad T; Roldán E; Mondelo N
Int J Clin Pharmacol Ther; 2022 Apr; 60(4):192-206. PubMed ID: 35103587
[TBL] [Abstract][Full Text] [Related]
28. Bioequivalence of an ezetimibe/simvastatin combination tablet and coadministration of ezetimibe and simvastatin as separate tablets in healthy subjects.
Migoya EM; Bergman A; Hreniuk D; Matthews N; Yi B; Roadcap B; Valesky R; Liu L; Riffel K; Groff M; Zhao JJ; Musson DG; Gambale J; Kosoglou T; Statkevich P; Lasseter KC; Laurent A; Johnson-Levonas AO; Murphy G; Gottesdiener K; Paolini JF
Int J Clin Pharmacol Ther; 2006 Feb; 44(2):83-92. PubMed ID: 16502768
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.
Kim Y; Son M; Lee D; Roh H; Son H; Chae D; Bahng MY; Park K
Clin Ther; 2013 Jul; 35(7):934-40. PubMed ID: 23870605
[TBL] [Abstract][Full Text] [Related]
30. Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects.
Oh MJ; Hwang HH; Kim HG; Lee GH; Cho YS; Lee SY; Kang SY; Cho KH; Lee YY; Lee YJ; Jang CG; Lee SY
Clin Ther; 2017 Jul; 39(7):1371-1379. PubMed ID: 28625505
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous quantitation of rosuvastatin and ezetimibe in human plasma by LC-MS/MS: Pharmacokinetic study of fixed-dose formulation and separate tablets.
Bhadoriya A; Sanyal M; Shah PA; Shrivastav PS
Biomed Chromatogr; 2018 Oct; 32(10):e4291. PubMed ID: 29782035
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers.
Seong SJ; Ohk B; Kang WY; Gwon MR; Kim BK; Cho S; Yang DH; Lee HW; Yoon YR
Adv Ther; 2019 Jul; 36(7):1642-1656. PubMed ID: 31119689
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects.
Cho YS; Lee SH; Lim HS; Bae KS
J Korean Med Sci; 2018 Oct; 33(41):e258. PubMed ID: 30288156
[TBL] [Abstract][Full Text] [Related]
34. A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial.
Hong SJ; Jeong HS; Ahn JC; Cha DH; Won KH; Kim W; Cho SK; Kim SY; Yoo BS; Sung KC; Rha SW; Shin JH; Han KR; Chung WS; Hyon MS; Lee HC; Bae JH; Rhee MY; Kwan J; Jeon DW; Yoo KD; Kim HS
Clin Ther; 2018 Feb; 40(2):226-241.e4. PubMed ID: 29402522
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the bioavailability and tolerability of fixed-dose combination glimepiride/metformin 2/500-mg tablets versus separate tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Korean volunteers.
Gu N; Kim BH; Rhim H; Chung JY; Kim JR; Shin HS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2010 Jul; 32(7):1408-18. PubMed ID: 20678687
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects.
Moon SJ; Jeon JY; Jang K; Yu KS; Lim Y; Kim MG
Drug Des Devel Ther; 2019; 13():2533-2542. PubMed ID: 31440035
[TBL] [Abstract][Full Text] [Related]
38. The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial.
Obońska K; Kasprzak M; Sikora J; Obońska E; Racki K; Goździkiewicz N; Krintus M; Kubica J
Trials; 2017 Jul; 18(1):316. PubMed ID: 28697767
[TBL] [Abstract][Full Text] [Related]
39. Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions.
Wu L; Xu C; Wu G; Zhou H; Lv D; Zhai Y; Huang Y; Tang W; Li F; Shentu J
Drug Des Devel Ther; 2019; 13():3331-3342. PubMed ID: 31571834
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.
Lee J; Rhee SJ; Lee S; Yu KS
Drug Des Devel Ther; 2018; 12():787-794. PubMed ID: 29670335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
